OTEZLA (Celgene Corporation)
Welcome to the PulseAid listing for the OTEZLA drug offered from Celgene Corporation. This Phosphodiesterase 4 Inhibitor [EPC],Phosphodiesterase 4 Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Celgene Corporation |
| NON-PROPRIETARY NAME: | apremilast |
| SUBSTANCE NAME: | APREMILAST |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Phosphodiesterase 4 Inhibitor [EPC],Phosphodiesterase 4 Inhibitors [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET, FILM COATED |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2014-04-03 |
| END MARKETING DATE: | 0000-00-00 |
OTEZLA HUMAN PRESCRIPTION DRUG Details:
| Item Description | OTEZLA from Celgene Corporation |
| LABELER NAME: | Celgene Corporation |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 30(mg/1) |
| START MARKETING DATE: | 2014-04-03 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 59572-631_66cc5840-c6ed-498d-b82b-45c7cb6fc578 |
| PRODUCT NDC: | 59572-631 |
| APPLICATION NUMBER: | NDA205437 |
Other APREMILAST Pharmaceutical Manufacturers / Labelers:
